This synthesis demonstrates the efficient construction of bufogargarizin B using a novel approach, highlighting its potential in pharmaceuticals.
Bufogargarizins are a class of unique 19-norbufadienolides isolated from the venom of Bufo bufo gargarizans. Here we report a concise synthesis of bufogargarizin B from inexpensive, commercially available dehydroepiandrosterone by means of a conformation-controlled skeletal reorganization approach. The synthesis features the rapid construction of the 5/7/6/5 tetracyclic core framework by means of a SmI₂-mediated ketone-allylic acetate transannular cyclization, and the installation of stereochemically diverse 5,7- and 7,5-fused ring systems through a biomimetic retro-aldol/transannular aldol cascade reaction. In addition, an efficient, scalable synthesis of 2-pyrone-5-boronate, a key building block for the introduction of the side chain of bufadienolides, has been developed, and the highly functionalized all-cis D ring of bufogargarizin B is installed by means of a series of highly chemo- and regioselective redox transformations. This work vividly demonstrates that conformational control plays a critical role in the precise installation of desired stereocenters in transannular cyclization products.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: